SUMMARY
Toxic shock syndrome (TSS) is a rare but potentially fatal toxin-mediated febrile illness 1 . We report a case of TSS complicated by life-threatening organ dysfunction with high TSS toxin-1 (TSST-1) and staphylococcus enterotoxin type A (SEA) levels that were successfully reduced by early introduction of plasma exchange.
CASE REPORT
A 14-year-old boy (weight 51 kg, height 167 cm) was admitted to the intensive care unit of our hospital with complaints of malaise, fever and shortness of breath, which had progressed over a period of 48 hours. On examination (Table 1) the patient was unconscious and cyanosed, with a bladder temperature of 40.8°C, blood pressure of 65/42 mmHg, heart rate of 183 beats/min and respiratory rate of 4 1/min. An erythematous rash was observed over most of his body. Laboratory data showing multiorgan dysfunction are shown in Table 2 .
The patient was immediately intubated and mechanically ventilated with 0.5 FiO 2 , 10 cmH 2 O pressure support and 5 cmH 2 O positive end-expiratory pressure. Arterial blood gas analysis showed acidaemia: pH 7.16, P a O 2 , 247 mmHg, P a CO 2 , 54 mmHg, base excess -9.9 mEq/l, and lactate 8.1 mmol/l. APACHE II score and Paediatric Index of Mortality 2 (PIM2) 2 on admission were 23 and -1.69 points (probability of death 15.5%), respectively. We suspected TSS or endotoxic shock based on the high body temperature (>38.9°C), tachycardia, hypotension, multiple organ dysfunction and diffuse erythema. Blood was collected on admission for blood culture and for measurement of levels of bacterial superantigens and/or endotoxin.
Central venous and double-lumen haemofiltration catheters were inserted into his right jugular and femoral veins, respectively. Despite fluid resuscitation with 2.5 l colloid (6% hydroxyethyl starch)/2 l crystalloid (acetated Ringers) including antibiotics (panipenam/betamipron) and continuous infusion of catecholamines (noradrenaline 0.3 µg.kg -1 .min -1 and dopamine 8 µg.kg -1 .min -1 ), the patient remained hypotensive (80/50 mmHg). Because respiratory function deteriorated (pH 7.28, P a O 2 , 75 mmHg and P a CO 2 50 mmHg with 0.7 FiO 2 ), and because the patient was still hypotensive (62/18 mmHg) at six hours after admission to the intensive care unit, plasma exchange was commenced in order to remove mediators that induce septic shock. The levels of superantigens were extremely high, but the endotoxin level was undetectable before plasma exchange ( Table 2 ). Methicillin-sensitive Staphylococcus aureus has grown in blood culture.
We used a KM 8800 ® (Kuraray, Kurashiki, Japan) for the plasma exchange pump and Plasmacure® for the plasma filter (0.6 m 2 , Kuraray, Kurashiki, Japan). Blood flow and ultrafiltration rates were 80 ml/min and 1.3 l/h respectively. Fresh plasma was infused at the rate that matched the hourly ultrafiltration, and the total volume of plasma replaced was 3.6 l. After the first plasma exchange, his circulatory state improved (blood pressure of 105/47 mmHg with noradrenaline 0.17 µg.kg -1 .min -1 and dopamine 8.0 µg.kg -1 .min -1 , Table 1 ). Respiratory function also improved (pH 7.50, P a O 2 , 106 mmHg, P a CO 2 38 mmHg with 0.4 FiO 2 ) and his body temperature decreased to 37.2°C. C-reactive protein (CRP) decreased from 14.4 to 5.1 mg/dl, and the concentration of superantigen decreased after the first plasma exchange ( Table 2) .
On the second day after ICU admission, blood pressure decreased again (data of Pre PMX in Table  1 ) and levels of the inflammatory markers CRP and white blood cell count (WBC) were remarkably increased (Table 2 ). In order to remove endogenous cannabinoids, we performed direct haemoperfusion (DHP) with a polymyxin B (PMX)-immobilized fibre (Toray, Tokyo, Japan). After DHP-PMX, his blood pressure recovered slightly, but we could not reduce the high rate infusions of catecholamines (noradrenaline 0.22 µg. Although the staphylococcus enterotoxin type A decreased, the concentration of TSST-1 was not changed by DHP-PMX. We also measured levels of the endogenous cannabinoids, anandamide and 2-arachidonyl glyceride before and after DHP-PMX. DHP-PMX did not reduce the plasma concentrations of anandamide and 2-arachidonyl glyceride (Table 2) . Since DHP-PMX had no effect on his clinical state, plasma exchange was carried out again on the second day. The patient's condition noticeably improved following the second plasma exchange (Table 1) , and the concentration of TSST-1 was reduced ( Table 2) . Plasma exchange greatly reduced the concentrations of both anandamide and 2-arachidonyl glyceride ( Table 2) . On the third day after intensive care admission, blood pressure was maintained with 6.0 µg.kg -1 min -1 dopamine, but inflammatory markers (WBC count and CRP) remained high ( Table 2) . A third plasma exchange was performed in order to remove superantigens and other mediators. After the third plasma exchange, WBC count was still high, but CRP, TSST-1 and staphylococcus enterotoxin type A decreased significantly (Table 2 ). Due to clinical improvement, he was extubated on the fourth day after intensive care admission and was discharged from hospital on the 24th day.
DISCUSSION
Current management of septic shock in the intensive care unit includes volume replacement, administration of vasopressor drugs, antibiotics and haemodialysis 3 . TSS, caused by Staphylococcus aureus and Streptococcus pyogenes (group A Streptococci), is a rare but potentially fatal toxin-mediated febrile illness 1 . Toxins released from bacteria induce and amplify the cytokine response, resulting in the progression to septic shock, disseminated intravascular coagulation, multiorgan dysfunction syndrome and subsequent death 3 . The mechanisms by which Grampositive organisms initiate septic shock and multiple organ injury are still unclear. Several studies have suggested roles for streptococcal pyrogenic exotoxin serotypes A, B, C and F 4,5 , staphylococcal enterotoxin A to E 4,5 , TSST-1 4-6 , Toll-like receptors 7 , NF-κB 7 , nitric oxide 8, 9 , peptidoglycan [9] [10] [11] , lipoteichoic acid 9,10,12 , cannabinoids 13, 14 , reactive oxygen species 15 , tumor necrosis factor 5, 11 , interleukin 6 (IL -6) 16 , IL -10 15 and M-toxin 4 . The polymyxin B (PMX)-immobilized fibre, which is available in Japan 17 , was originally developed for selective removal of endotoxin. Kawamata et al 18 reported that DHP-PMX decreased endotoxin levels and improved the hyperdynamic state in methicillinresistant Staphylococcus aureus (MRSA) septic patients. Recently, specific plasmapheresis with DHP-PMX has been reported to be effective for removal of not only endotoxin but also endogenous cannabinoids 19, 20 . In certain shock conditions, platelets and macrophages produce at least two different endogenous cannabinoids, anandamide and 2-arachidonyl glyceride, which may be paracrine mediators of hypotension during shock, acting via the CB1 cannabinoid receptor subtype localized in the peripheral vasculature 13, 21 . One of the reasons why DHP-PMX did not effectively remove the cannabinoids in the present case might be excess production of toxins and mediators by bacteria. Our scientific knowledge of the complex timing of mediator release and balance during TSS may be insufficient to develop successful therapeutic adsorption with DHP-PMX for this syndrome. Fenwick et al 22 reported the ability to reduce superantigen activity from infected animals and reduce mortality by on-line haemoperfusion over a column containing fibres with the ability to adsorb superantigens. That might be another reason why plasma exchange, but not DHP-PMX, successfully removed anandamide and 2-arachidonyl glyceride in the present case.
In conclusion, this report shows the time course of the concentrations of anandamide and 2-arachidonyl glyceride in a patient with TSS during introduction of plasma exchange and DHP-PMX, and that early introduction of plasma exchange could result in a rapid reduction of circulating toxins and mediators for the treatment of life-threatening multiple organ dysfunction. The development of the selective toxins/mediators adsorptive techniques will depend on an improved knowledge of the factors to be removed or replaced during severe sepsis.
